Centrally mediated vasodilation of the rat's tail by angiotensin II. 1996

M J Fregly, and N E Rowland
Department of Physiology, College of Medicine, University of Florida, Gainesville 32610, USA.

Acute peripheral administration of angiotensin II (AngII) to rats vasodilates the tail and reduces both metabolic rate and body temperature. To assess the role of the brain in these responses to AngII, a discrete lesion was aimed at the subfornical organ (SFO). Such lesions are known to abolish drinking and other responses to circulating AngII. A control group was sham-operated. Following recovery from surgery, dipsogenic responses to administration of AngII (150 micrograms/kg, SC) were tested. All lesioned rats failed to drink. One week later, the changes in colonic (TC) and tail skin (TSK) temperatures were measured following an identical injection of AngII. As reported before, control rats showed a substantial rise in in TSK (maximum rise 2.5 degrees C after 12 min). In contrast, the lesioned rats showed very little rise (0.3 degrees C) in TSK, significantly less than controls. The maximal drop in TC of the control group was slightly more (0.3 degrees C) than that of the lesioned group (0.2 degrees C), but the difference was not significant. The rats were, next, acutely exposed to cold (5 degrees C). Control rats showed a significantly larger decrease in TSK than lesioned rats. Lesions were verified both anatomically and using the functional metric of AngII-induced Fos-like immunoreactivity (Fos-IR). AngII induced strong Fos-IR in the SFO, median preoptic nucleus (MnPO), and in the magnocellular hypothalamic regions of control rats. The lesions ablated the anterior part of the SFO and dorsal MnPO, and greatly attenuated AngII-induced Fos-IR in the magnocellular hypothalamic regions. Thus, there appears to be central (SFO/MnPO) mediation of both the increase in TSK following administration of AngII and the decrease in TSK in the cold.

UI MeSH Term Description Entries
D008297 Male Males
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013623 Tail An extension of the posterior of an animal body beyond the TORSO. Tails
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M J Fregly, and N E Rowland
September 1966, The Journal of pharmacology and experimental therapeutics,
M J Fregly, and N E Rowland
December 1982, European journal of pharmacology,
M J Fregly, and N E Rowland
June 1971, Life sciences. Pt. 1: Physiology and pharmacology,
M J Fregly, and N E Rowland
November 1971, Physiology & behavior,
M J Fregly, and N E Rowland
January 1976, The Indian journal of medical research,
M J Fregly, and N E Rowland
May 1969, Japanese heart journal,
M J Fregly, and N E Rowland
February 1987, Acta physiologica Scandinavica,
M J Fregly, and N E Rowland
September 2017, Trends in endocrinology and metabolism: TEM,
M J Fregly, and N E Rowland
March 1971, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!